PURIDOX

This brand name is authorized in Nigeria.

Active ingredients

The drug PURIDOX contains one active pharmaceutical ingredient (API):

1	Epirubicin UNII 22966TX7J5 - EPIRUBICIN HYDROCHLORIDE
	Epirubicin is a cytotoxic active antibiotic from the anthracycline group. The mechanism of action of epirubicin is related to its ability to bind to DNA. Cell culture studies have shown rapid cell penetration, localisation in the nucleus and inhibition of nucleic acid synthesis and mitosis.
	Read more about Epirubicin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3937	Solution for infusion	Puridox Injection_ INJ_SOL 50 mg 1 x 1's (in vial)	Solution for Injection. Sterile orange red colored lyophilized mass PURIDOX INJECTION EPIRUBICIN HYDROCHLORIDE BP 50MG EPIRUBICIN HYDROCHLORIDE BP 50MG METHYL PARABEN BP 10MG LACTOSE BP Q.S. B4-3937 Drugs Imported Products 1X1VIAL Prescription Only Medicine (POM) 03/12/2023 MANOLA PHARMACEUTICALS LTD, BLOCK 89A, OBA KAYODE AKNYEMI WAY, AMUWO ODOFIN LAGOS LAGOS LAGOS 8103078742 regulatorymanola@gmail.com NAPROD LIFE SCIENCES PVT. LTD, G-17/1, M.I.D.C., BOISAR THANE, INDIA, India	28/08/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01DB03	Epirubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3937